Table 1.
Anaplasma platys | C.Mycoplasma haematoparvum | Mycoplasma haemocanis | Trypanosoma cruzi | Leishmania sp. | Acanthocheilonema reconditum | Co-infection | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% (95%CI) | % (95%CI) | % (95%CI) | % (95%CI) | % (95%CI) | % (95%CI) | % (95%CI) | ||||||||
Overall prevalence |
36.0 (27.1–44.9) |
30.6 (22.0-39.2) |
27.9 (19.6–36.3) |
17.1 (10.1–24.1) |
4.5 (0.6–8.4) |
0.9 (0.0-2.6) |
34.2 (25.4–41.1) |
|||||||
Sex | ||||||||||||||
Female |
30.9 (16.9–44.9) |
23.8 (10.9–36.6) |
21.4 (9.0-33.8) |
28.6 (14.9–42.2) |
9.5 (0.6–18.4) |
0 |
38.1 (23.4–52.7) |
|||||||
Male |
39.1 (27.6–50.6) |
34.8 (23.5–46.0) |
31.9 (20.8–42.8) |
10.1 (3.0-17.2) |
1.4 (0.0-4.3) |
1.4 (0.0-4.3) |
33.3 (22.2–44.4) |
|||||||
Age | ||||||||||||||
Adult |
28.7 (19.2–38.2)* |
39.1 (28.8–49.3)* |
33.3 (23.4–43.2)* |
17.2 (9.3–25.1) |
4.6 (0.2-9.0) |
1.1 (0.0-3.3) |
41.4 (31.0-51.7)* |
|||||||
Juvenile |
62.5 (43.1–81.9)* |
0* |
8.3 (0.0-19.4)* |
16.7 (1.7–31.5) |
4.2 (0.0-12.2) |
0 |
12.5 (0-25.7)* |
|||||||
R.s. MA | MA ± SE | MA ± SE | MA ± SE | |||||||||||
Infected | 7.2 ± 2.6* | 5.3 ± 1.4 | 7.0 ± 2.9 | - | - | - | - | |||||||
No-infected | 3.0 ± 0.6* | 4.1 ± 1.3 | 3.5 ± 0.8 | - | - | - | - |
95%CI: 95% Confidence Intervals; * significant differences between groups; R.s.; “Rhipicephalus sanguineus S.S.” s.s.ss; MA, mean abundance; SE, standard error